The Future Of Regenerative Medicine Today.
Rejuvimed International is a health care center whose treatments are based on regenerative medicine. Such medicine regenerates tissues, organs and damaged bone structures through the use of products obtained from one’s own body. These biological products could be plasma rich in growth factors, autologous cells and protein based products from the bone marrow. They are safe therapies and do not generate any kind of rejection capable of returning full function to structures and body organs.
Rejuvimed combines regenerative tissue therapies with antioxidant therapies thus strengthening the regenerative effect by controlling the chronic inflammatory processes. Regenerative therapy also includes a preventive concept such as the use of chelation therapy, which improves general circulation by reducing the cholesterol plaques deposited in artery walls, which in time might eventually produce severe obstructions such as strokes and cardiovascular disease.
The regenerative therapies also are a therapeutic control to chronic diseases such as diabetes mellitus, rheumatoid arthritis, osteo-articular degenerative diseases such as osteoarthritis, Parkinson’s, fibromyalgia, peripheral neuropathy of the sciatic nerve, deterioration of vitality and some infectious diseases.
From the aesthetic point of view, the stimulation with plasma rich in platelets (PRP), retards the aging process of the skin, the pigmentation, cell regeneration, all which allows for a better quality of the skin, less flaccidity and expression lines.
Rejuvimed is a Healthcare Centre directed by Dr. M. Alejandra Calderón, internist specialized in immunology and hematology with training in proteomics and an MD in Pharmacogenetics, who personally supervises and takes part in the treatments applied to patients. Also part of the staff is Dr. Patricia G. Orozco Varela, with training in apheresis, with a degree in the use of PRP (plasma rich in platelets) both medical and aesthetical ozone therapy, stem cells, clinical nutrition in chronic diseases and cancer, and takes part in the medical treatment received by patients as well as in their treatment programs.